v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
COSTS AND EXPENSES:        
Research and development $ 4,627,636 $ 2,465,392 $ 9,260,830 $ 5,081,729
General and administrative 1,401,053 1,156,842 3,127,391 2,499,160
Total costs and expenses 6,028,689 3,622,234 12,388,221 7,580,889
LOSS FROM OPERATIONS (6,028,689) (3,622,234) (12,388,221) (7,580,889)
OTHER INCOME:        
Interest income, net 659 10,309 3,021 11,356
Total other income 659 10,309 3,021 11,356
NET LOSS $ (6,028,030) $ (3,611,925) $ (12,385,200) $ (7,569,533)
BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE $ (0.11) $ (0.26) $ (0.25) $ (0.65)
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE 52,763,809 13,793,548 50,464,274 11,591,605

Source